Metric Deep Dive: Understanding Pacific Biosciences of California Inc (PACB) Through its Ratios

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

After finishing at $1.26 in the prior trading day, Pacific Biosciences of California Inc (NASDAQ: PACB) closed at $1.38, up 9.52%. In other words, the price has increased by $9.52 from its previous closing price. On the day, 7.23 million shares were traded. PACB stock price reached its highest trading level at $1.4 during the session, while it also had its lowest trading level at $1.26.

Ratios:

Our goal is to gain a better understanding of PACB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.02 and its Current Ratio is at 6.92. In the meantime, Its Debt-to-Equity ratio is 11.37 whereas as Long-Term Debt/Eq ratio is at 11.36.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 18 ’25 when Van Oene Mark sold 26,836 shares for $1.31 per share. The transaction valued at 35,182 led to the insider holds 1,920,035 shares of the business.

MARK VAN OENE bought 26,836 shares of PACB for $35,174 on Aug 18 ’25. On May 19 ’25, another insider, Farmer Michele, who serves as the insider of the company, sold 5,195 shares for $1.00 each. As a result, the insider received 5,200 and left with 269,259 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 414512000 and an Enterprise Value of 801997440. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.66 while its Price-to-Book (P/B) ratio in mrq is 6.74. Its current Enterprise Value per Revenue stands at 5.137 whereas that against EBITDA is -3.553.

Stock Price History:

The Beta on a monthly basis for PACB is 1.88, which has changed by -0.13749999 over the last 52 weeks, in comparison to a change of 0.1513431 over the same period for the S&P500. Over the past 52 weeks, PACB has reached a high of $2.72, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 0.19%, while the 200-Day Moving Average is calculated to be -7.24%.

Shares Statistics:

The stock has traded on average 9.31M shares per day over the past 3-months and 9229820 shares per day over the last 10 days, according to various share statistics. A total of 300.35M shares are outstanding, with a floating share count of 264.44M. Insiders hold about 11.97% of the company’s shares, while institutions hold 55.94% stake in the company. Shares short for PACB as of 1753920000 were 41870792 with a Short Ratio of 4.50, compared to 1751241600 on 47367175. Therefore, it implies a Short% of Shares Outstanding of 41870792 and a Short% of Float of 15.86.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.